News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,632 Results
Type
Article (47484)
Company Profile (316)
Press Release (684832)
Multimedia
Podcasts (70)
Webinars (14)
Section
Business (212273)
Career Advice (2249)
Deals (36458)
Drug Delivery (115)
Drug Development (82676)
Employer Resources (191)
FDA (16639)
Job Trends (15551)
News (357031)
Policy (33628)
Tag
Academia (2791)
Academic (2)
Accelerated approval (5)
Adcomms (24)
Allergies (90)
Alliances (52072)
ALS (97)
Alzheimer's disease (1432)
Antibody-drug conjugate (ADC) (137)
Approvals (16631)
Artificial intelligence (291)
Autoimmune disease (23)
Automation (16)
Bankruptcy (370)
Best Places to Work (12082)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (211)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (297)
Cancer (2354)
Cardiovascular disease (186)
Career advice (1888)
Career pathing (33)
CAR-T (166)
Cell therapy (458)
Cervical cancer (21)
Clinical research (67030)
Collaboration (892)
Company closure (2)
Compensation (564)
Complete response letters (21)
COVID-19 (2694)
CRISPR (44)
C-suite (260)
Cystic fibrosis (102)
Data (2309)
Decentralized trials (2)
Denatured (32)
Depression (45)
Diabetes (278)
Diagnostics (6641)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (124)
Drug pricing (111)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (88573)
Editorial (40)
Employer branding (25)
Employer resources (161)
Events (117905)
Executive appointments (765)
FDA (18013)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (803)
Gene editing (115)
Generative AI (23)
Gene therapy (330)
GLP-1 (770)
Government (4624)
Grass and pollen (4)
Guidances (130)
Healthcare (19636)
Huntington's disease (26)
IgA nephropathy (29)
Immunology and inflammation (127)
Indications (30)
Infectious disease (2845)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (99)
Interviews (357)
IPO (16893)
IRA (42)
Job creations (3896)
Job search strategy (1607)
Kidney cancer (10)
Labor market (45)
Layoffs (498)
Leadership (20)
Legal (8150)
Liver cancer (77)
Lung cancer (333)
Lymphoma (158)
Machine learning (8)
Management (62)
Manufacturing (336)
MASH (74)
Medical device (13979)
Medtech (13984)
Mergers & acquisitions (20141)
Metabolic disorders (728)
Multiple sclerosis (85)
NASH (23)
Neurodegenerative disease (96)
Neuropsychiatric disorders (27)
Neuroscience (1999)
NextGen: Class of 2025 (6933)
Non-profit (4715)
Now hiring (41)
Obesity (391)
Opinion (226)
Ovarian cancer (80)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (246)
Patient recruitment (117)
Peanut (49)
People (60130)
Pharmaceutical (74)
Pharmacy benefit managers (19)
Phase I (20887)
Phase II (29509)
Phase III (21977)
Pipeline (1318)
Policy (152)
Postmarket research (2651)
Preclinical (9113)
Press Release (72)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (254)
Rare diseases (393)
Real estate (6345)
Recruiting (72)
Regulatory (23029)
Reports (56)
Research institute (2519)
Resumes & cover letters (386)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (75)
Series A (141)
Series B (91)
Service/supplier (18)
Sickle cell disease (56)
Special edition (16)
Spinal muscular atrophy (152)
Sponsored (33)
Startups (3833)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (47)
The Weekly (36)
Vaccines (735)
Venture capitalists (44)
Weight loss (257)
Women's health (37)
Worklife (18)
Date
Today (231)
Last 7 days (929)
Last 30 days (3086)
Last 365 days (33515)
2025 (11848)
2024 (36325)
2023 (41266)
2022 (52383)
2021 (57064)
2020 (55717)
2019 (48716)
2018 (36797)
2017 (33589)
2016 (33279)
2015 (39378)
2014 (32942)
2013 (28043)
2012 (30318)
2011 (30994)
2010 (29472)
Location
Africa (808)
Alabama (54)
Alaska (7)
Arizona (243)
Arkansas (14)
Asia (40316)
Australia (6603)
California (6437)
Canada (2069)
China (544)
Colorado (280)
Connecticut (281)
Delaware (159)
Europe (88508)
Florida (952)
Georgia (223)
Hawaii (1)
Idaho (62)
Illinois (581)
India (28)
Indiana (329)
Iowa (11)
Japan (171)
Kansas (107)
Kentucky (26)
Louisiana (13)
Maine (62)
Maryland (935)
Massachusetts (4820)
Michigan (245)
Minnesota (421)
Mississippi (2)
Missouri (90)
Montana (27)
Nebraska (25)
Nevada (69)
New Hampshire (66)
New Jersey (1821)
New Mexico (30)
New York (1826)
North Carolina (1039)
North Dakota (9)
Northern California (2815)
Ohio (218)
Oklahoma (15)
Oregon (34)
Pennsylvania (1436)
Puerto Rico (13)
Rhode Island (35)
South America (1201)
South Carolina (26)
South Dakota (1)
Southern California (2418)
Tennessee (106)
Texas (965)
United States (24381)
Utah (196)
Virginia (156)
Washington D.C. (70)
Washington State (573)
West Virginia (3)
Wisconsin (68)
732,632 Results for "biolife solutions inc formerly cryomedical sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioLife Solutions Reports First Quarter 2025 Financial Results
May 8, 2025
·
14 min read
Press Releases
BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
17 min read
Business
BioLife Solutions Reports First Quarter 2024 Financial Results
BioLife Solutions, Inc. announced financial results for the three months ended March 31, 2024 and affirmed its revenue guidance for 2024.
May 9, 2024
·
17 min read
BioForest
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
BioLife Solutions, Inc., a leading supplier of bioproduction tools and services for the cell and gene therapy and broader biopharma markets, announced the introduction of the CryoCase, an addition to its CellSeal product line.
May 29, 2024
·
2 min read
Business
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2023, and introduces 2024 revenue guidance.
February 29, 2024
·
17 min read
Press Releases
BioLife Solutions Reports Third Quarter 2024 Financial Results
November 12, 2024
·
19 min read
BioForest
BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences
BioLife Solutions, Inc. today announced that Roderick de Greef , Chief Executive Officer, and Troy Wichterman, Chief Financial Officer, will present and meet with current and prospective investors at the following March Investor Conferences.
March 4, 2024
·
1 min read
Press Releases
BioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage Subsidiary
November 13, 2024
·
3 min read
Business
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader biopharma markets, today announced the Company’s first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024.
April 30, 2024
·
1 min read
Business
BioLife Solutions Reports Third Quarter 2023 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”) today announced financial results for the third quarter and nine months of 2023.
November 9, 2023
·
15 min read
1 of 73,264
Next
